✦ LIBER ✦

PCN4 LIKELIHOOD OF A SUBSEQUENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) EVENT IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC CHEMOTHERAPY (MEC/HEC)

✍ Scribed by B Feinberg; J Gilmore; S Haislip; J Jackson; G Jain; S Balu; D Buchner

Book ID: 118614096
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 78 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)71901-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Costs of uncontrolled chemotherapy-induc

Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy

✍ Ya-Chen Tina Shih; Ying Xu; Linda S. Elting 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract ## BACKGROUND. Chemotherapy‐induced nausea and vomiting (CINV) is among the most feared side effects of cancer treatment. Poorly controlled CINV may lead to additional office visits or emergency room admissions, thus increasing the overall costs of cancer care. The objective of the pro

Resource utilization and costs associate

Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting

✍ Thomas A. Burke; Tami Wisniewski; Frank R. Ernst 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 237 KB

A randomized study of aprepitant, ondans

A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy

✍ Winnie Yeo; F. K. F. Mo; J. J. S. Suen; W. M. Ho; S. L. Chan; W. Lau; J. Koh; W. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 184 KB

Efficacy of palonosetron (PAL) compared

Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis

✍ Tobias Engel Ayer Botrel; Otávio Augusto C. Clark; Luciana Clark; Luciano Paladi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 722 KB

PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOM

PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING

✍ C. Craver; J. Gayle; S. Balu; D. Buchner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN164 TWO DIFFERENT DOSES OF PALONOSETR

PCN164 TWO DIFFERENT DOSES OF PALONOSETRON (PAL) FOR PREVENTION OF CHEMOTHERAPY-INDUCED VOMITING (CIV) IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC (MOHE) TREATMENT: SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

✍ T Engel; O Clark; L Paladini; E Faleiros; LG Clark; B Pegoretti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB